VTRO (Vitro Biopharma) OCF Yield %: 0.00 (As of Jul. 02, 2026)

What is Vitro Biopharma OCF Yield %?

Vitro Biopharma VTRO OCF Yield % is 0.00 as of Jul. 02, 2026. The stock has 6 warning signs investors should review.

OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

As of today, Vitro Biopharma's Trailing 12-Month Cash Flow from Operations is $-2.22 Mil, and Market Cap is $0.00 Mil. Therefore, Vitro Biopharma's OCF Yield % for today is 0.00%.

The historical rank and industry rank for Vitro Biopharma's OCF Yield % or its related term are showing as below:

VTRO's OCF Yield % is not ranked ^*
in the Biotechnology industry.
Industry Median: -8.13
* Ranked among companies with meaningful OCF Yield % only.

Vitro Biopharma's OCF Margin % for the quarter that ended in Oct. 2022 was %.

Vitro Biopharma OCF Yield % Explanation

Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Vitro Biopharma OCF Yield % Related Terms

Vitro Biopharma OCF Yield % Historical Data

* Premium members only.

The historical data trend for Vitro Biopharma's OCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vitro Biopharma OCF Yield % Chart

Vitro Biopharma Annual Data

Trend

Oct09

Oct10

Oct11

Oct12

Oct13

Oct14

Oct15

Oct17

Oct21

Oct22

OCF Yield %

Get a 7-Day Free Trial

0.00

Vitro Biopharma Quarterly Data
	Oct00	Oct01	Oct02	Oct03	Oct04	Oct05	Oct06	Oct07	Oct08	Oct09	Oct10	Oct11	Oct12	Oct13	Oct14	Oct15	Oct17	Oct21	Oct22
OCF Yield %	Get a 7-Day Free Trial														0.00	0.00	0.00	0.00	0.00

Vitro Biopharma OCF Yield % Calculation

OCF Yield % is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

Vitro Biopharma's OCF Yield % for the fiscal year that ended in Oct. 2022 is calculated as

OCF Yield %	=	Cash Flow from Operations	/	Market Cap
	=	-2.217	/	0
	=	N/A%

Vitro Biopharma's annualized OCF Yield % for the quarter that ended in Oct. 2022 is calculated as

OCF Yield %	=	Cash Flow from Operations	*	Annualized Factor	/	Market Cap
	=	-2.217	*	4	/	0
	=	N/A%

Frequently Asked Questions Learn more about OCF Yield % →

What does a OCF Yield % of 0.00 mean?

Vitro Biopharma (VTRO) has a OCF Yield % of 0.00 as of Jul. 02, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Vitro Biopharma and its competitors.

Is Vitro Biopharma's OCF Yield % too high?

Vitro Biopharma's current OCF Yield % is 0.00.

How does Vitro Biopharma's OCF Yield % compare to ?

Vitro Biopharma's OCF Yield % of 0.00 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good OCF Yield % for a Biotechnology company?

A good OCF Yield % depends on the Biotechnology industry context. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high OCF Yield % mean?

A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Vitro Biopharma and its competitors. Vitro Biopharma's current OCF Yield % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Vitro Biopharma stock overvalued right now?

Vitro Biopharma (VTRO) has a current OCF Yield % of 0.00. The current OCF Yield % is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is OCF Yield % calculated?

OCF Yield % is calculated from a company's financial statements. For Vitro Biopharma (VTRO), the current OCF Yield % is 0.00 as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Vitro Biopharma Business Description

Industry Healthcare Biotechnology

Comparable Companies

Address 4621 Technology Drive, Golden, CO, USA, 80403

Website http://www.vitrobiopharma.com

Vitro Diagnostics Inc is a US-based company, which is dedicated to providing high-quality commercialized cell lines, media, and stem cell technology for applications in stem cell research, drug discovery, and therapies. In addition, it also provides tools for clinical development focused on Mesenchymal Stem Cells (MSCs). Further, it offers cancer-associated fibroblasts (CAFs), which are used in the discovery of a new type of CAFs present in pancreatic cancer tumors, called pancreatic stellate cells. Geographically business activities are functioned through the region of United States.